← Back to Search

Usual Care for Dementia (D-CARE Trial)

N/A
Waitlist Available
Led By Alan Stevens, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

D-CARE Trial Summary

This trial will help to determine if a health system-based or community-based care model is more effective and cost-effective for persons with dementia and their caregivers.

D-CARE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Caregiver Distress
Severity of Dementia-related Behavioral Symptoms
Secondary outcome measures
Caregiver Self-Efficacy: 4-item self-efficacy scale
Level of Distress Experienced by the Caregiver in Response to Dementia-related Psychiatric and Behavioral Symptoms
Severity of Depression in Caregivers
Other outcome measures
Caregiver Assessment of Dementia Care
Caregiver Rating of Dementia Care Quality
Clinical Benefit
+18 more

Side effects data

From 2016 Phase 3 trial • 300 Patients • NCT02008565
38%
Constipation
10%
Urinary tract infection
8%
Abdominal pain
8%
Fall
7%
Abdominal distension
7%
Diarrhoea
6%
Nausea
6%
Headache
6%
Back pain
3%
Upper respiratory tract infection
2%
Osteoarthritis
1%
Pulmonary embolism
1%
Anaemia
1%
Haemorrhoids
1%
Ventricular tachycardia
1%
Ankle fracture
1%
Vascular pseudoaneurysm
1%
Hyperglycaemia
1%
Transient ischaemic attack
1%
Chronic obstructive pulmonary disease
1%
Pancreatitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo - Education Only
Loperamide - Education Only
Loperamide - Exercise Plus Biofeedback
Placebo - Exercise Plus Biofeedback

D-CARE Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Usual CareExperimental Treatment1 Intervention
Dementia care that most closely corresponds to traditional care. This arm will also receive standardized educational materials (hard copies and internet-based resources), referral to the Alzheimer's Association 1-800 national helpline to speak to a master's level consultant for decision-making support, crisis assistance, and caregiver education, as well as referral to local programs and services.
Group II: Health Systems-Based Dementia CareActive Control1 Intervention
Dementia care that is based in the health care system, which partners with community-based organizations to provide comprehensive, coordinated, patient-centered care. The health system-based dementia care arm uses a Dementia Care Specialist (Nurse Practitioner or Physician Assistant) supervised by a physician to tailor and facilitate dementia care delivery in collaboration with the primary care physician (co-management). The Health Systems-Based Dementia Care arm is based on UCLA's Alzheimer's and Dementia Care Program.
Group III: Community-Based Dementia CareActive Control1 Intervention
Dementia care that is based in community organizations, which gives equal attention to patients and their primary family or friend caregivers. The community-based dementia care arm uses Care Consultants (social workers, nurses, or licensed therapist). Patients with dementia are engaged in the program whenever possible. Caregivers can be the sole program participant, when patients are too impaired. The program establishes a long-term relationship between Care Consultants and families. The exact content of assistance provided is tailored to the preferences of individual patients and caregivers, and is holistic in the range of potential concerns of problems addressed. The Community-Based Dementia Care arm is based on the Benjamin Rose Institute on Aging's Care Consultation Program.

Find a Location

Who is running the clinical trial?

Yale UniversityOTHER
1,837 Previous Clinical Trials
2,726,237 Total Patients Enrolled
7 Trials studying Dementia
508 Patients Enrolled for Dementia
Baylor Scott and White HealthOTHER
15 Previous Clinical Trials
154,080 Total Patients Enrolled
University of TexasOTHER
186 Previous Clinical Trials
140,303 Total Patients Enrolled
2 Trials studying Dementia
1,844 Patients Enrolled for Dementia

Media Library

Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT03786471 — N/A
Dementia Research Study Groups: Health Systems-Based Dementia Care, Community-Based Dementia Care, Usual Care
Dementia Clinical Trial 2023: Usual Care Highlights & Side Effects. Trial Name: NCT03786471 — N/A
Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT03786471 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How widely has this experiment been deployed across healthcare facilities?

"4 medical sites are enrolling patients into this clinical trial, including University of Texas Medical Branch in Galveston, Baylor Scott & White in Temple and Wake Forest Baptist Medical Center in Winston-Salem. Additionally, there are an additional 4 locations on board with the study."

Answered by AI

Is this research venture still open to new participants?

"Upon review of the clinicaltrials.gov website, it is evident that this research endeavor is no longer recruiting patients - first posted on June 28th 2019 and last updated March 25th 2022. Fortunately, 401 other trials are currently in need of participants to continue their scientific progress."

Answered by AI
~378 spots leftby Mar 2025